True North Therapeutics' Series A - II Round

True North Therapeutics raised a round of funding on June 17, 2014.

True North Therapeutics is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of first-in-class product candidates for complement-mediated diseases…

Articles about True North Therapeutics' Series A - II Round: